Charles River Laboratories International (CRL) Earnings Date, Estimates & Call Transcripts

$204.35

-0.03 (-0.01%)

(As of 09:34 AM ET)

CRL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Crypto 101 Media

This Crypto Is Set to Explode in August

With the 2024 Bitcoin Halving, there's a potential HUGE bull run for altcoins. While everyone's chasing the latest DeFi craze or the next hot meme coin, the savviest investors are quietly positioning themselves for a different kind of explosion. This year's Bitcoin halving bull run is about to unleash a tidal wave in a completely undervalued sector of the crypto market.

Click here to review my research and see how this coin is at the center of a disruptive blockchain s

Charles River Laboratories International Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	2	$2.05	$2.73	$2.39
Q2 2024	2	$2.38	$2.68	$2.53
Q3 2024	2	$3.00	$3.09	$3.05
Q4 2024	2	$3.25	$3.37	$3.31
FY 2024	8	$10.68	$11.87	$11.28
Q1 2025	2	$2.53	$2.58	$2.56
Q2 2025	2	$2.74	$2.76	$2.75
Q3 2025	2	$3.21	$3.41	$3.31
Q4 2025	2	$3.54	$3.59	$3.57
FY 2025	8	$12.02	$12.34	$12.18
Q1 2026	1	$3.13	$3.13	$3.13

CRL Earnings Date and Information

Charles River Laboratories International has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off prior year's report dates.

Charles River Laboratories International Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/13/2024 (Estimated)	-	-	-	-	-	-	-
5/9/2024	Q1 2024	$2.05	$2.27	+$0.22	$3.24	$997.24 million	$1.01 billion
2/14/2024	Q4 2023	$2.39	$2.46	+$0.07	$1.30	$991.25 million	$1.01 billion
11/8/2023	Q3 2023	$2.35	$2.72	+$0.37	$3.75	$1.00 billion	$1.03 billion
8/9/2023	Q2 2023	$2.63	$2.69	+$0.06	$3.49	$1.05 billion	$1.06 billion
5/11/2023	Q1 2023	$2.59	$2.78	+$0.19	$3.55	$988.10 million	$1.03 billion
2/22/2023	Q4 2022	$2.75	$2.98	+$0.23	$2.31	$1.04 billion	$1.10 billion
Get the Latest News and Ratings for CRL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter.
11/2/2022	Q3 2022	$2.51	$2.63	+$0.12	$3.38	$978.65 million	$989.16 million
8/3/2022	Q2 2022	$2.74	$2.77	+$0.03	$3.41	$995.12 million	$973.13 million
5/4/2022	Q1 2022	$2.71	$2.75	+$0.04	$3.69	$908.64 million	$913.93 million
2/16/2022	Q4 2021	$2.42	$2.49	+$0.07	$2.31	$888.27 million	$905.05 million
11/2/2021	Q3 2021	$2.58	$2.70	+$0.12	$3.39	$902.03 million	$895.90 million
8/3/2021	Q2 2021	$2.38	$2.61	+$0.23	$3.50	$880.72 million	$914.61 million
5/3/2021	Q1 2021	$2.19	$2.53	+$0.34	$3.86	$798.52 million	$824.60 million
2/16/2021	Q4 2020	$2.11	$2.39	+$0.28	$1.97	$755.98 million	$790.99 million
10/29/2020	Q3 2020	$1.80	$2.33	+$0.53	$2.63	$715.63 million	$743.30 million
8/5/2020	Q2 2020	$1.27	$1.58	+$0.31	$1.82	$638.70 million	$682.60 million
5/7/2020	Q1 2020	$1.46	$1.84	+$0.38	$2.66	$692.11 million	$707.06 million
2/11/2020	Q4 2019	$1.83	$2.01	+$0.18	$2.41	$685.46 million	$691.10 million
11/6/2019	Q3 2019	$1.64	$1.69	+$0.05	$1.92	$674.08 million	$668.00 million

Charles River Laboratories International Earnings - Frequently Asked Questions

When is Charles River Laboratories International's earnings date?: Charles River Laboratories International has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates. Learn more on CRL's earnings history.
What guidance has Charles River Laboratories International issued on next quarter's earnings?: Charles River Laboratories International updated its FY 2024 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of 9.900-10.200 for the period, compared to the consensus earnings per share estimate of 10.990. The company issued revenue guidance of $3.9 billion-$4.0 billion, compared to the consensus revenue estimate of $4.2 billion.
How much revenue does Charles River Laboratories International generate each year?: Charles River Laboratories International (NYSE:CRL) has a recorded annual revenue of $4.08 billion.
How much profit does Charles River Laboratories International generate each year?: Charles River Laboratories International (NYSE:CRL) has a recorded net income of $474.62 million. CRL has generated $8.50 earnings per share over the last four quarters.
What is Charles River Laboratories International's price-to-earnings ratio?: Charles River Laboratories International (NYSE:CRL) has a trailing price-to-earnings ratio of 24.04 and a forward price-to-earnings ratio of 18.59. The price/earnings-to-growth ratio is 2.32.
What is Charles River Laboratories International's EPS forecast for next year?: Charles River Laboratories International's earnings are expected to grow from $10.99 per share to $12.35 per share in the next year, which is a 12.37% increase.